Cellares
Develops automated cell therapy manufacturing platforms
$257MSeries D
Role not disclosedLoading investors…
Activity from announced rounds
Develops automated cell therapy manufacturing platforms
Develops inhaled therapies for severe respiratory diseases
Pitching Willett Advisors? Send the deck from a free RoundOS data room and see which pages they read.